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Abstract: The launch of ‘Rapid Recommendations’ by the Grading of Recommendations Assessment,
Development and Evaluation (GRADE) group, in collaboration with Making GRADE the Irresistible
Choice (MAGIC) and the British Medical Journal (BMJ), is a very interesting recent development
in e-healthcare. Designed to respond quickly to developments that have created new decision
situations, their first project resulted from the arrival of minimally invasive Transcatheter Aortic
Valve Implantation (TAVI) as an alternative to Surgical Aortic Valve Replacement (SAVR), for patients
with symptomatic severe aortic stenosis. The interactive MAGIC decision aid that accompanies a
Rapid Recommendation and is the main route to its clinical implementation, represents a major
advance in e-health, for a cardiovascular decision in this case. However, it needs to go further in
order to facilitate fully person-centred care, where the weighted preferences of the individual person
are elicited at the point of decision, and transparently integrated with the best (most personalised)
estimates of option performances, to produce personalised, preference-sensitive option evaluations.
This can be achieved by inputting the collated GRADE evidence on the criteria relevant in the
TAVI/SAVR choice into a Multi-Criteria Decision Analysis-based decision support tool, generating a
personalised, preference-sensitive opinion. A demonstration version of this add-on to the MAGIC
aid, divested of recommendations, is available online as proof of method.
Keywords: aortic stenosis; SAVR; TAVI; GRADE; MAGIC; person-centred care; decision support;
Multi-Criteria Decision Analysis; preferences
1. Introduction
Until a few years ago, a 70-year-old with severe symptomatic aortic stenosis faced a typical life
expectancy of 50% at two years, with escalating heart failure and reduced quality of life—unless they
were at ‘low or intermediate’ surgical risk, in which case they had the option of open heart surgery for
valve replacement (Surgical Aortic Valve Replacement or SAVR).
The arrival of Transcatheter Aortic Valve Implantation (TAVI), with delivery of the replacement
valve through the femoral artery, created a new, minimally invasive option. The resulting TAVI
or SAVR decision was the first addressed by the newly-launched collaboration between Grading
of Recommendations Assessment, Development and Evaluation (GRADE), Making GRADE the
Irresistible Choice (MAGIC), and the British Medical Journal (BMJ) (hereafter GRADE+) to produce
and publish ‘trustworthy recommendations . . . in response to potentially practice changing evidence,
so called ‘Rapid Recommendations’ [1] (p. 2).
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In the systematic review and meta-analysis of randomized controlled trials undertaken as part of
the Rapid Recommendation production process, it was confirmed that neither was a dominant option.
Each was superior on some criteria and inferior on others.
Mortality was reduced with transfemoral TAVI compared with SAVR by about 3%, stroke by
2%, acute kidney injury by 5%, bleeding by 24%, new onset atrial fibrillation by 18%, and
duration of index admission by three days. These benefits, however, come with associated
harms. TAVI was associated with an increased risk of experiencing symptoms of heart failure
by about 6% (2% of which were moderate or severe), permanent pacemaker insertion by
about 15%, and aortic valve reintervention over the short term by about 1% [1] (p. 8).
It was noted that TAVI was an increasingly popular alternative to SAVR, even when this was not
in line with current practice guidelines. These recommended either TAVI or SAVR in patients at high
surgical risk—defined as a Society of Thoracic Surgeons predicted risk of mortality (STS-PROM) score
of 8% or less, but recommended SAVR over TAVI for lower surgical risk patients. Despite this, half
of the TAVI centers in Europe were found to perform TAVI in intermediate-risk patients (STS-PROM
4–8%) and 10% of centers did so in low-risk patients (risk score <4%).
The questions of interest in this paper do not concern the quality of the evidence produced as the
basis of the new Rapid Recommendations, nor the grading of that evidence. They relate to the form the
recommendations take, and the way they were generated on the basis of the evidence, but especially
to the framing and content of the interactive online MAGIC decision aid. This is presented as the main
route to clinical implementation of the recommendations, whether in the clinic or in the formulation of
clinical practice guidelines. MAGIC decision aids undoubtedly represent a major advance in e-health,
in this case in cardiovascular medicine. However, the aids can be much enhanced by an add-on that
transforms them into e-health decision support tools that meets key requirements of person-centred
decision making. Such an add-on is introduced in a later section as proof of method.
2. Materials
The materials drawn on are the BMJ article introducing the Rapid Recommendations on TAVI vs
SAVR [2], other supporting papers [1,3] and the online MAGIC app (https://app.magicapp.org/app#
/guideline/1308). (It is stressed in all these sources that patients without symptoms, or with milder
aortic disease, are not covered.)
2.1. The Rapid Recommendations
Separate recommendations were arrived at for four age groups. The short summary quotations
following are from the BMJ online presentation [2].
• Under 65: Strong recommendation for SAVR. ‘Since durability of TAVI valves is unknown,
younger people may place a high value on avoiding a second aortic valve placement.’
• 65 and under 75: Weak recommendation for SAVR. ‘People who wish to avoid open-heart surgery
are likely to favour TAVI. People who place more value on avoiding a second aortic valve
placement are likely to choose surgery.’
• 75 and under 85: Weak recommendation for TAVI. Same as statement for previous group.
• 85 and over: Strong recommendation for TAVI. ‘The uncertainty around long-term durability of
TAVI valves is not likely to concern those over 85. These older patients are also likely to place a
high value on avoiding open heart surgery.’
In summary, the ’age-stratified recommendations reflect that TAVI is probably preferable to those
over 75 years old, whereas SAVR is likely preferable to those under 75 years’.
More elaborated statements appear in the decision aid in the MAGIC app (link above). For the
65–75 age group, for example:
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• We suggest SAVR rather than TAVI [Weak recommendation].
• Benefits outweigh harms for the majority, but not for everyone. The majority of patients would
likely want this option.
• Preference and values: Patients are likely to place different value on benefits and harms associated
with TAVI. Patients aged 75 or younger—with a life expectancy well beyond 10 years—are likely
to place a particularly high value on avoiding need for a second aortic valve replacement and
are likely to choose surgery. Patients who place a high value on avoiding initial open heart
surgery and are willing to accept an increased risk for aortic valve reintervention are likely to
choose TAVI. A systematic review of values and preferences provided limited evidence to inform
our judgements.
GRADE classifies recommendations as either ‘strong’ or ‘weak’:
• Strong recommendations mean that most informed patients would choose the recommended
management and that clinicians can structure their interactions with patients accordingly
• Weak recommendations mean that patients’ choices will vary according to their values and
preferences, and clinicians must ensure that patients’ care is in keeping with their values
and preferences
• Strength of recommendation is determined by the balance between desirable and undesirable
consequences of alternative management strategies, quality of evidence, variability in values and
preferences, and resource use [4] (p. 1051).
How were the specific recommendations arrived at in the valve replacement case? The Evidence
to Decision (EtD) framework [5] is the generic GRADE answer:
Panels should consider the evidence about the benefits and harms of the options and how
certain that evidence is. They also need to consider how much the people affected directly by
the decision value the benefits and harms, whether there is important uncertainty about this,
and whether there is important variability in how much people value the benefits and harms.
They must then consider all these criteria together to make a judgment about the balance
between the desirable and undesirable effects of the option [5] (p. 7, italics supplied).
In the present cardiovascular case, the account of the recommendation process provided is:
When moving from evidence to recommendations, the panel integrated information on
benefits and harms of treatment alternatives, quality of evidence, and values and preferences
of patients as well as acceptability, feasibility, and resources [2] (p. 2, italics supplied).
The GRADE account is therefore limited to saying that the recommendations resulted from
making judgments about the various elements of evidence and then integrating them by a process of
consideration. However, the concern here is not so much with the process as with the product, and
in particular, because of its centrality in person-centred care, with the treatment of the individual’s
preferences. The existence of preference heterogeneity is acknowledged—as ‘variability in values’—but
this leads not to the abandonment of recommendations, but to the ‘weakening’ of them:
Uncertainty about how much those affected (patients or their carers) value the outcomes of
interest can be a reason to make a weak (conditional) rather than a strong recommendation.
Variability in how patients value the main outcomes (to the extent that individuals
with different values would make different decisions) is another reason for a weak
recommendation. For example, some patients might place a lower value on avoiding a
stroke compared with avoiding serious gastrointestinal bleeding or the burden of warfarin
treatment than other patients [5] (p. 4).
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The suggestion (in an earlier quotation) that patients whose preferences are not in accord with
those of ‘most informed people’ should, by implication, be ignored, and a strong recommendation
implemented, is concerning. Does the MAGIC decision aid (link above), explicitly designed for use in
clinical consultations, help ensure preference-sensitive decision making for all patients?
2.2. The MAGIC Decision Aid
The online MAGIC decision aid which accompanies the Rapid Recommendations is intended to
be delivered by the clinician in a shared decision-making context:
This interactive tool for shared-decision making is designed to help you meet your patients’ needs by:
• Exploring what outcomes they wish to discuss
• Communicating the benefits and harms of each alternative, as well as their (un)certainty
• Discussing practical issues associated with each alternative
This decision aid does not replace clinical judgment. Adapt it to the context as needed and use your
own communication style.
The essence of the aid can only adequately be conveyed by seeing its two main visual components.
They are reproduced here in the belief that both this reproduction and the subsequent development of
an adaptive add-on, are in accordance with the licencing:
This is an Open Access article distributed in accordance with the Creative Commons
Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute,
remix, adapt, build upon this work non-commercially, and license their derivative
works on different terms, provided the original work is properly cited and the use
is non-commercial [2] (Footnote).
It contains the following statement along with an active link to the MAGIC app containing the
reproduced figures:
For a fully interactive version of this graphical summary of recommendations, please visit:
https://doi.org/10.1136/bmj.i5085
The Disclaimer to the MAGIC infographic is also important to note, both substantively and
because it also applies to the future adaptation of the aid, undertaken as proof of method:
Disclaimer: This infographic is not a validated clinical decision aid. This information is
provided without any representations, conditions or warranties that it is accurate or up to
date. BMJ and its licensors assume no responsibility for any aspect of treatment administered
with the aid of this information. Any reliance placed on this information is strictly at the
user’s own risk.
Figure 1 is the summary MAGIC infographic for the 65–75 age group. Figure 2 is the matching
picture of the full set of individual evidence boxes, envisaged as being selected, loaded, and discussed
one-by-one during a shared decision-making sequence.
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Figure 1. Infographic in Making GRADE the Irresistible Choice (MAGIC) aid for 65–75 year-olds.
Figure 2. Cont.
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Figure 2. Information boxes in the MAGIC aid for 65–75-year-olds.
3. Method
The questions to be asked at this point are why the recommendation is needed in the first place if
personalised decision support is being offered, and why it is displayed prominently at the top of the
infographic as part of the decision aid (Figure 1). Rhetorically, can a genuine decision aiding process
take place within the frame of a recommendation for the decision, even if it is ‘weak’?
Apart from this problematic framing, the impressive infographic presented as part of a MAGIC
decision aid, may paradoxically increase the difficulty of processing the information into a decision,
simply because it is set out so clearly and attractively. GRADE+, albeit in good company, holds a
highly optimistic view of the cognitive ability of humans (including health professionals) to synthesise
even the modest quantities of disparate information in this infographic into an accountable decision,
i.e., a decision for which even a modestly explanatory account can be provided. This optimism is
associated with the belief that communicating information as information, in a well-organised and
attractively laid-out form, is both empowering and constitutes effective decision support.
In contrast, such a presentation of information can easily be seen as overpowering, not
empowering, possibly even as constituting ‘symbolic violence’ [6]. Only communicating information
within an explicit decision framework constitutes decision support, as opposed to information support for
decision making. Visually, a ‘decisiographic’, not an infographic, is needed for this task. It is argued
elsewhere that online decision support tools based on Multi-Criteria Decision Analysis (MCDA) are
good candidates for person-centred decision making and that the Annalisa implementation of MCDA
provides a simple ‘decisiographic’, displaying evidence, preferences, and the scores which result from
their integration on a ‘one-screen-shows-all’ [7]. A screen capture appears in a later section (Figure 3)
introducing the decision support add-on to the MAGIC aid.
Person-centred care requires the preferences of the person-as-patient to be elicited at the point
of decision, and transparently integrated with the best (most personalised) available estimates of
option performances, to produce preference-sensitive option evaluations. The lack of population-level
evidence on the ‘balance of benefits and harms’, regretted by the present recommendation developers
(‘A systematic review of values and preferences provided limited evidence to inform our judgements’.)
is not a problem, and the further research called for is not needed. Group average preferences, such as
those derived in Discrete Choice Experiments or Conjoint Analyses, are not relevant in person-centred
care [8,9] and their continued claims of clinical relevance are examples of the methodological research
tail wagging the clinical practice dog. It is the harm–benefit balance of the individual making the
TAVI–SAVR decision that needs to be obtained and applied, at the point of decision.
Such individualised support is also arguably essential for the giving and obtaining of informed
consent under the recent Montgomery ruling in the UK, which substituted the ‘reasonable patient’
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for the ‘reasonable practitioner’ standard [10]. The reasonable patient will certainly want to know
how well their options perform on the considerations that matter to them, considerations which they
themselves weight in importance.
The required decision support tool must be practical and useful. It must meet the SMART
criteria—Specific, Measurable, Achievable, Relevant, and Timely—to the extent that these are
reasonable in the specific decision context. More simply, the decision support must be ‘fast and frugal’.
It must be pitched at the most appropriate point (trade-off) on the ‘rigour-relevance’ continuum and
be cost-effective as a contributor to the quality of the decision. It will therefore be a long way from a
highly analytical and quantitative evaluation of the type undertaken by the UK National Institute for
Health and Care Excellence, but equally distant from an expert intuition only-based verbal deliberation
or evaluation in the otheropposite direction.
Multi-Criteria Decision Analysis (MCDA) as implemented in Annalisa [7] can provide the basis
for such ‘fast and frugal’ decision support tools. They provide an opinion on the worth of each
Option by combining its Ratings (how well it performs on relevant Criteria) with its Weightings (how
important is a criterion relative to the other criteria), making the opinion a preference-sensitive one.
Introductory materials and numerous examples of the implementation of the technique are available at
http://cafeannalisa.org.uk, including short video ‘Powtoons’. These draw on the increasingly popular
comparison websites for goods and services, such as Which (UK), Tænk (Denmark), Consumer Reports
(US), and Choice (Australia), all of which employ a basic and accessible form of MCDA. Examples
taken from them are useful ’warm-ups’ to health applications.
Alan Williams lamented attempts to escape from the daunting demands of decision making
by engaging only in deliberative consideration based on verbal judgments, rather than requisite
quantification and calculation. As he argued, whether in guideline formation panels or clinical
consultations, ‘consideration’ unsupported by coherent quantitative analysis lacks transparent
accountability and hence provides ample cover for bias and discrimination. Adopting this position, he
was prepared for ‘the hostility it is likely to engender from those who mistakenly equate precision
with lack of humanity’ [11] (p. 120). This is also possible in relation to the current proposal.
4. Result: An Add-On Decision Support Tool for the TAVI versus SAVR Choice
The basic inputs into the decision support tool are seven featured criteria in the MAGIC decision
aid, along with the summary evidence on how TAVI and SAVR perform on them, as their Ratings.
Three considerations, where the individual is the expert, are added and they are asked to supply their
personal performance ratings, based on the relevant information taken from the aid, including its
‘Practical Considerations’ section. These 10 become the criteria in the interactive decision support tool,
for which the person provides a set of criterion importance Weightings. In line with the principles
of value-based compensatory MCDA, the Weightings and Ratings are then integrated in expected
value calculations to generate a preference-sensitive opinion—pair of Option Scores—for the person to
discuss. They can revise their Weightings in the light of the displayed Ratings. (The Ratings for the
seven MAGIC criteria are ‘locked’ so as to prevent editing and possible misrepresentation.)
A sample of the Annalisa output screen appears in Figure 3. This example, for an under 65 year old,
is one where a reasonable set of criterion importance Weightings and respondent-sourced performance
Ratings produces an opinion favouring TAVI—in contrast to the strong SAVR recommendation for this
age group.
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Figure 3. Screen capture from the MAGIC add-on decision support tool.
GRADE uses four verbal levels to classify the quality (‘certainty’) of the evidence. In our
conception of a decision support tool, adjusting for this is not a task to be left outside the tool
for ‘consideration’. MCDA requires quantitative inputs, so the GRADE certainty levels are mapped on
to the 0–1.0 scale: Very low = 0.1; Low = 0.4; Moderate = 0.7; High = 1.0. (These particular mappings
are open for debate, but the principle of numerical mapping is not.) The pair of certainty-adjusted
Scores for TAVI and SAVR is presented in the aid alongside the unadjusted ones, so that the effect of
certainty adjustment is clearly visible.
To engage with the tool, on a demonstration-only basis, go to https://ale.rsyd.dk and enter 1491
as survey ID. Feedback is invited.
While offering substantive support for this particular decision, any engagement with this sort
of tool is likely to have spillover empowerment benefits in the form of enhanced health decision
literacy—and indeed generic decision literacy—through the introduction to MCDA it provides.
5. Discussion
The first thing to note is that there has been interference with person-centred care in the
pathway that has led to the TAVI or SAVR decision node being reached. The Recommendation
does not question the restriction of the SAVR option to persons at ‘low or intermediate’ surgical
risk. Recommending an 8% threshold for surgical mortality risk may be in providers’ interest
to preserve their place in some league table, or professional morale and job satisfaction, but it
infringes a key principle of person-centred care [12]. A patient should be free to decide between
TAVI, SAVR, and a life expectancy of three years with much reduced quality of life, whatever their
surgical risk. What they need is preference-sensitive support in making such a tough decision.
In fact, all population-based threshold-based risk classifications threaten person-centred care and
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good clinical practice, by interfering with obtaining the legally, and ethically, required informed and
preference-based consent [13,14].
Where does this leave GRADE and GRADE+? Person-centred care requires the individual
person’s preferences to be elicited at or near the point of decision, so that their decisional autonomy is
respected, and so that their legal informed consent can be obtained to any provider action following
from a decision.
Decision support is needed in such a complex decision, but the support must not be biased by
being framed within a recommendation provided, or not provided, on the basis of which of two
categories the evidence fits according to a guideline panel. The TAVI or SAVR decision is a near-perfect
example of why this should be avoided, and why the under 65 s and over 85 s should be offered
exactly the same support as those between those ages. The opinion emerging from the add-on decision
support tool correctly reflects the age-specific evidence for death and stroke, but is not ‘ageist’ in any
other way.
The possibility of decision aids being useful is acknowledged in GRADE, but conditionally:
As clinicians become more aware of variability in patients’ values and preferences, they
are turning to structured decision aids to facilitate the decision making process. A strong
recommendation indicates that use of a decision aid is unnecessary—almost all informed
patients will make the same choice. A weak recommendation indicates that a decision aid
could be useful [4] (p. 1049).
On the contrary, in person-centred healthcare, a preference-sensitive, decision analytic support tool
should always be offered. If practice guidelines are to survive in this context, the relationship between
guidelines and decision aids needs to be the reverse of that suggested by van der Weijden, et al., where
the guidelines are developed first and the decision aids derived from them later [15]. While they note
the disconnect between the groups responsible for guideline and aids, and suggest greater collaboration
is the answer, they overlook the fundamental distinction between establishing a good evidence base in
healthcare research and making preference-sensitive decisions in healthcare practice.
The important function of groups such as GRADE and MAGIC is to develop and present the
evidence base in the light of the structure of the decision aid, eschewing the issue of recommendations
which necessarily involve preference judgments. It is particularly worrying when authors appear
to feel entitled to decide whether decisions are ‘preference-sensitive’ or not. All decisions are
preference-sensitive, even if all agree on the preferences involved in a decision. If a proxy is needed,
the proxy should be using the preferences they believe the patient holds, not the ones they think the
patient should hold. The evidence should be presented in a personalised and preference-sensitive
decision support tool, uncontaminated by any prior assumptions about sensitivity.
While the argument made here may seem radical, in most respects it merely echoes the views of
Margaret McCartney and colleagues [16]. Here are some selected excerpts, but their whole paper is
essential reading:
. . . there is the danger of guideline recommendations being applied to people who do not
place the same values on those recommendations as their clinician, or indeed those intended
by the guideline creators . . . Surveys have shown that most patients wish either to share
decision making with their clinicians or to take the decisions themselves. Guidelines should
enable, not subvert, this process . . . guideline producers need to resist the temptation to
tell clinicians and patients what to do. Making recommendations for the population, often
based on expert opinion, reinforces the power imbalance between professional expertise
and the patient’s values and preferences . . . The impact of the side effect at the level of the
population may be high if the treatment is used widely, and may be considered important
enough to withdraw the treatment from general use. This removes a potentially valuable
treatment option for someone who has perhaps found the treatment highly effective and has
a very low absolute risk of being harmed . . .
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It is difficult to personalise recommendations from guidelines, even for those skilled in
evidence based medicine . . . Usable decision aids should [therefore] now be seen as one of
the most important end products for evidence based medicine [16] (pp. 1–2).
In keeping with GRADE, MAGIC, and the BMJ, the aim here is to provide support for more
transparent and accountable decisions, made within typical time and practice constraints and cognitive
limitations of all parties. Our own decision support tools, intended for apomediative (at home) use, as
well as in subsequent clinical encounters [17,18], do not seek to meet the standard normative checklist
for decision aid development, produced without any notion of timeliness or cost-effectiveness [19].
Paradoxically, setting these longer, more expensive and demanding parameters for decision aids
can have the effect of encouraging poorer, analytically unsupported, decision making. Any specific
decision support tool must be evaluated empirically and comparatively and only against the actual
decision-making process that would be followed in its absence. The normatively best is the enemy
whenever it discourages the development and use of the empirically better. In this respect, the
current add-on tool is not a good example, since it builds on an aid that does meet the demanding
standard requirements.
The limitations of the current proposal are all those associated with attempts to introduce decision
aids into clinical practice [20,21], perhaps increased by its grounding in the MCDA approach to
decision support. This approach is currently seen as difficult to reconcile with conventional models of
clinical reasoning. However, since it is proving difficult to introduce patient preferences explicitly and
transparently into these models, the MCDA approach is making slow progress towards acceptance.
Whether this is a limitation is therefore a function of one’s assessment of the state of current practice.
Implementing the type of decision support proposed here as an add-on to the MAGIC
decision aid would have significant clinical implications; the more so the greater the role guideline
recommendations play in actual clinical care. Most guideline recommendations are based on evidence
regarding the main benefit criterion in a decision and on the perceived average preferences of patients.
Person-centred care in a heterogeneous population requires that such recommendations should be
interpreted in the light of a wider multi-criteria analysis of all the benefits and harms associated
with the individual patient’s options, as assessed using their personal preferences. While this may
be seen as required in ethical and legal practice, there are serious doubts as to the extent to which
it is delivered within the pressures of practice. Concerns about the extra clinical time and resources
needed to implement this approach to decision support are best met by considering its introduction
apomediatively, through e-health and m-health technologies.
6. Conclusions
Whether or not the widely-disseminated MAGIC aid addresses the full complexity of the valve
replacement decision, as viewed by patients and revealed in qualitative studies [22], is left to others to
decide. In an original decision support tool, as opposed to this add-on, other criteria might be added,
along with the mandatory ‘do nothing’ option. However, this add-on to provide preference-sensitive
decision support is seen as a response to the GRADE+ invitation encouraging ‘adaptation of
recommendations to allow contextualisation’ in pursuit of improved healthcare. Feedback is welcomed.
Author Contributions: J.D. conceived and wrote the paper, incorporating the revisions and additions of M.K.K.
Funding: This research received no external funding. The software used for the demonstration version of the
decision support tool was installed at https://ale.rsyd.dk as part of a nationally-funded project to develop
decision support tools based on Multi-Criteria Decision Analysis (Danish National Board of Health/SATS J.nr.
1-1010/116/27).
Conflicts of Interest: Jack Dowie has a financial interest in the Annalisa software implementation of MCDA, used
here to demonstrate the decision support tool but does not benefit from its non-commercial use.
Med. Sci. 2018, 6, 109 11 of 12
References
1. Siemieniuk, R.A.; Agoritsas, T.; Manja, V.; Devji, T.; Chang, Y.; Bala, M.M.; Thabane, L.; Guyatt, G.H.
Transcatheter versus surgical aortic valve replacement in patients with severe aortic stenosis at low and
intermediate risk: Systematic review and meta-analysis. BMJ 2016, 354, i5130. [CrossRef] [PubMed]
2. Vandvik, P.O.; Otto, C.M.; Siemieniuk, R.A.; Bagur, R.; Guyatt, G.H.; Lytvyn, L.; Whitlock, R.; Vartdal, T.;
Brieger, D.; Aergeerts, B.; et al. Transcatheter or surgical aortic valve replacement for patients with severe,
symptomatic, aortic stenosis at low to intermediate surgical risk: A clinical practice guideline. BMJ 2016,
354, i5085. [CrossRef] [PubMed]
3. Lytvyn, L.; Guyatt, G.H.; Manja, V.; Siemieniuk, R.A.; Zhang, Y.; Agoritsas, T.; Vandvik, P.O. Patient values
and preferences on transcatheter or surgical aortic valve replacement therapy for aortic stenosis: A systematic
review. BMJ Open 2016, 6, e014327. [CrossRef] [PubMed]
4. Guyatt, G.H.; Oxman, A.D.; Kunz, R.; Falck-Ytter, Y.; Vist, G.E.; Liberati, A.; Schünemann, H.J. GRADE:
Going from evidence to recommendations. BMJ 2008, 336, 1049–1051. [CrossRef] [PubMed]
5. Moberg, J.; Oxman, A.D.; Rosenbaum, S.; Schünemann, H.J.; Guyatt, G.H.; Flottorp, S.; Glenton, C.; Lewin, S.;
Morelli, S.; Rada, G.; et al. The GRADE Evidence to Decision (EtD) framework for health system and public
health decisions. Health Res. Policy Syst. 2018, 16, 45. [CrossRef] [PubMed]
6. Kaltoft, M.K.; Nielsen, J.B.; Salkeld, G.; Dowie, J. Health informatics can avoid committing symbolic violence
by recognizing and supporting generic decision-making competencies. Stud. Health Technol. Inf. 2015, 218,
172–177.
7. Dowie, J.; Kaltoft, M.K.; Salkeld, G.; Cunich, M. Towards generic online multicriteria decision support in
patient-centred health care. Health Expect 2013, 18, 689–702. [CrossRef] [PubMed]
8. Kaltoft, M.K.; Nielsen, J.B.; Salkeld, G.; Dowie, J. Can a Discrete Choice Experiment contribute to
person-centered healthcare? Eur. J. Pers. Centered Healthcare 2015, 3, 431–437. [CrossRef]
9. Kaltoft, M.K.; Nielsen, J.B.; Salkeld, G.; Dowie, J. Preferences cannot be treated as epidemiological
characteristics in person-centred care: A riposte. Eur. J. Pers. Centered Healthcare 2016, 4, 6–9. [CrossRef]
10. Cheung, E.; Goodyear, G.; Yoong, W. Medicolegal update on consent: The Montgomery Ruling. Obstet.
Gynaecol. 2016, 18, 171–172. [CrossRef]
11. Williams, A.H.; Cookson, R.A. Equity-efficiency trade-offs in health technology assessment. Int. J. Technol.
Assess. Health Care 2006, 22, 1–9. [CrossRef] [PubMed]
12. Dowie, J.; Wildman, M. Choosing the surgical mortality threshold for high risk patients with stage la
non-small cell lung cancer: Insights from decision analysis. Thorax 2002, 57, 7–10. [CrossRef] [PubMed]
13. Kaltoft, M.K.; Nielsen, J.B.; Dowie, J. Separating risk assessment from risk management poses legal and
ethical problems in person-centred Care. Stud. Health Technol. Inf. 2018, 251, 23–26.
14. Kaltoft, M.K.; Nielsen, J.B.; Dowie, J. Risk thresholds and risk classifications pose problems for person-centred
care. Stud. Health Technol. Inf. 2018, 251, 19–22.
15. vand der Weijden, T.; Boivin, A.; Burgers, J.; Schünemann, H.J.; Elwyn, G. Clinical practice guidelines and
patient decision aids. An inevitable relationship. J. Clin. Epidemiol. 2012, 65, 584–589. [CrossRef] [PubMed]
16. McCartney, M.; Treadwell, J.; Maskrey, N.; Lehman, R. Making evidence based medicine work for individual
patients. BMJ 2016, 353, 1–6. [CrossRef] [PubMed]
17. Dowie, J.; Kaltoft, M.K. The future of health is self-production and co-creation based on apomediative
decision support. Med. Sci. 2018, 6, 66. [CrossRef] [PubMed]
18. Dowie, J.; Kaltoft, M.K. Preference-sensitive apomediative decision support is key to facilitating
self-produced health. Stud. Health Technol. Inf. 2018, 255, 132–136.
19. Elwyn, G.; O’Connor, A.M.; Bennett, C.; Newcombe, R.G.; Politi, M.; Durand, M.-A.; Drake, E.;
Joseph-Williams, N.; Khangura, S.; Saarimaki, A.; et al. Assessing the quality of decision support technologies
using the International Patient Decision Aid Standards instrument (IPDASi). PLoS ONE 2009, 4, e4705.
[CrossRef] [PubMed]
20. Elwyn, G.; Scholl, I.; Tietbohl, C.; Mann, M.; Edwards, A.G.; Clay, C.; Légaré, F.; van der Weijden, T.;
Lewis, C.L.; Wexler, R.M.; et al. “Many miles to go . . . ”: A systematic review of the implementation of
patient decision support interventions into routine clinical practice. BMC Med. Inf. Decis. Mak. 2013, 13
(Suppl. 2), S14. [CrossRef] [PubMed]
Med. Sci. 2018, 6, 109 12 of 12
21. Wyatt, K.D.; Branda, M.E.; Anderson, R.T.; Pencille, L.J.; Montori, V.M.; Hess, E.P.; Ting, H.H.; LeBlanc, A.
Peering into the black box: A meta-analysis of how clinicians use decision aids during clinical encounters.
Implement Sci. 2014, 9, 26. [CrossRef] [PubMed]
22. Lauck, S.B.; Baumbusch, J.; Achtem, L.; Forman, J.M.; Carrol, S.L.; Cheung, A.; Ye, J.; Wood, D.A.; Webb, J.G.
Factors influencing the decision of older adults to be assessed for transcatheter aortic valve implantation:
An exploratory study. Eur. J. Cardiovasc. Nurs. 2016, 15, 486–494. [CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
